This study is not yet accepting patients
Assessment of Safety of the Use of Fenfluramine in Children with Dravet Syndrome Under 24 Months of Age
Summary
- Eligibility
- for people ages 12 months to 24 months (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Joseph Sullivan, MD
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Joseph Sullivan, MD
Professor, Neurology, School of Medicine. Authored (or co-authored) 55 research publications
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of Colorado, Denver
- ID
- NCT06598449
- Phase
- Phase 4 research study
- Study Type
- Interventional
- Participants
- Expecting 12 study participants
- Last Updated